îæ€çŽ¢
îæ€çŽ¢
î
Cardiff Oncology Inc
CRDFîãŠã©ãããªã¹ãã«è¿œå
1.270USD
-0.020-1.55%
çµå€Â 07/02, 13:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
86.83Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
åçäºæž¬
é貚: USD æŽæ°æå»: 2026-07-01Cardiff Oncology Incã®çŸåšã®åçäºæž¬ã¹ã³ã¢ã¯8.00ã§ããã€ãªãã¯ãããžãŒ & å»çç 究æ¥çã§ã¯387瀟äž166äœã§ãã ç®æšæ ªäŸ¡ã®å¹³åã¯10.00ã§ãæé«ã¯19.00ãæäœã¯3.50ã§ãã
ã¢ããªã¹ãè©äŸ¡
8
人ã®ã¢ããªã¹ãäºæ³ã«åºã¥ã
è²·ã
çŸåšã®è©äŸ¡
7.500
ç®æšæ ªäŸ¡
+490.55%
äžæäœå°
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
åæ¥ä»ç€Ÿæ¯èŒ
562
åèš
5
äžå€®å€
6
å¹³å
äŒç€Ÿå
è©äŸ¡
ã¢ããªã¹ã
Cardiff Oncology Inc
CRDF
8
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
CRISPR Therapeutics AG
CRSP
26
1
2
3
...
113
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
財åäºæž¬
EPS
åç
çŽå©ç
EBIT
äºæž¬å€
å®çžŸå€
ãããã質å
Cardiff Oncology Inc ã®æ¬¡ã®ååæã®åçã¯ãããã§ãã?
îCardiff Oncology Inc ã®äºæ³åç㯠70.71K ã§ãã
Cardiff Oncology Inc ã®ç®æšæ ªäŸ¡ã¯ãããã§ãã?
îã¢ããªã¹ãã¯ãCardiff Oncology Inc ã®ç®æšæ ªäŸ¡ã USD 10.00 ãšäºæ³ããæé«äºæ³ã¯ USD 19.00ãæäœäºæ³ã¯ USD 3.50 ãšäºæ³ããŠããŸãã
Cardiff Oncology IncCRDF ã®æè¿ã® 1 æ ªåœããã®å©çã¯ã©ããªã£ãŠããŸãã?
îåžå Žäºæ³ã¯ USD -0.18 ã§ããããCardiff Oncology IncCRDF ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD -0.11 ã§ããã次ã®ååæã® EPS 㯠USD -0.16 ãšäºæ³ãããŸãã
Cardiff Oncology Inc ã«å¯Ÿããã¢ããªã¹ãã®è©äŸ¡ã¯äœã§ãã?
î8 ã¢ããªã¹ãã«ãã Cardiff Oncology Inc æ ªã®è©äŸ¡ã«åºã¥ããšãã»ãšãã©ã®ã¢ããªã¹ã㯠買ã ã®ãã¬ã³ããæ¯æããŠããŸããä»ã®ã¢ããªã¹ãã®æèŠãèæ
®ããçµæãæçµçã« Cardiff Oncology Inc ã®æ ªäŸ¡ã¯ è²·ã ãšè©äŸ¡ãããŸããããã¯ååŒã«é¢ããã¢ããã€ã¹ã§ã¯ãªãããšã«æ³šæããŠãã ããããã¯ãç¬èªã®åæãè¡ãå¿
èŠããããŸãã